Respiratory and post-viral
Breathlessness and post-viral disability create strong demand for regenerative claims, while both conditions contain heterogeneous patient groups and endpoints.
What the registry pattern says
COPD has the largest MSC registry footprint in this group (10 query results; 4 recruiting in the stored snapshot). COPD has the largest exosome footprint (1). These are query-result counts, not deduplicated patients or proof of benefit.
Require objective lung or functional measures, a clear phenotype and follow-up long enough to separate an intervention signal from rehabilitation and natural fluctuation.
Condition × therapy-class snapshot
| Condition | MSC | MSC recruiting | HSCT-family | Exosomes |
|---|---|---|---|---|
| COPD | 10 | 4 | 2 | 1 |
| Long COVID | 9 | 1 | 0 | 1 |
Source: ClinicalTrials.gov API v2 stored snapshot. Category totals add query results and may contain overlapping studies; use condition pages for interpretation.
Interactive/editorial page by the StemCellAtlas research team. Where registry or literature counts appear, they use the dated 2026-08-29 snapshot. Browser-only tools do not send or store answers. Page generated 2026-08-29. See our editorial standards.